TipRanks
BriaCell Therapeutics Corp (TSE:BCT)
TSX:BCT
Canadian Market
BCT
BriaCell Therapeutics
RESEARCH TOOLSreports
Want to see TSE:BCT full AI Analyst Report?

BriaCell Therapeutics (BCT) Income Statement

111 Followers

BriaCell Therapeutics Income Statement

Last quarter (Q4 2026), BriaCell Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, BriaCell Therapeutics's net income was C$-12.13M. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jul 26Jul 25Jul 24Jul 23Jul 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -121.09K$ -107.93K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 36.46M$ 27.43M$ 33.33M$ 23.27M$ 15.29M
Depreciation and Amortization
$ 121.09K$ 107.93K$ 83.90K$ 15.27K$ 15.27K
EBITDA
$ -36.46M$ -27.43M$ -4.85M$ -23.26M$ -26.82M
Operating Income
$ -36.58M$ -27.54M$ -33.33M$ -23.27M$ -15.29M
Other Income/Expenses
$ 739.66K$ 656.60K$ 28.40M$ 2.97M$ -11.55M
Pretax Income
$ -35.84M$ -26.88M$ -4.93M$ -20.30M$ -26.84M
Net Income
$ -35.42M$ -26.63M$ -4.79M$ -20.30M$ -26.84M
Per Share Metrics
Basic EPS
$ -7.07$ -62.95$ -43.68$ -195.00$ -259.50
Diluted EPS
$ -7.07$ -62.95$ -43.68$ -195.00$ -259.50
Weighted Average Shares Outstanding
 5.01M 423.11K 109.70K 104.13K 103.29K
Weighted Average Shares Outstanding (Diluted)
 5.01M 423.11K 109.70K 104.13K 103.29K

BriaCell Therapeutics Earnings and Revenue History